{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:29:16Z","timestamp":1773235756357,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.addbeh.2005.12.029","type":"journal-article","created":{"date-parts":[[2006,2,11]],"date-time":"2006-02-11T12:14:40Z","timestamp":1139660080000},"page":"1628-1649","source":"Crossref","is-referenced-by-count":61,"title":["An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants"],"prefix":"10.1016","volume":"31","author":[{"given":"Nassima","family":"Ait-Daoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Robert J.","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bankole A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2005.12.029_bib1","unstructured":"Ait-Daoud, N. (2005). Relationship between 5-HT transporter function and craving among Hispanic patients with alcoholism. In M. Galanter (Chair), New pharmacologic approaches to alcoholism. Symposium conducted at the May 2005 meeting of the American Psychiatric Association and sponsored by the American Academy of Addiction Psychiatry, Atlanta, GA."},{"issue":"Suppl. 7","key":"10.1016\/j.addbeh.2005.12.029_bib2","first-page":"141","article-title":"Side effect profile on two different starting doses of topiramate [abstract 2.233]","volume":"40","author":"Alapati","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.addbeh.2005.12.029_bib3","series-title":"Diagnostic and statistical manual of mental disorders, DSM-IV-TR","first-page":"191","article-title":"Substance-related disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.addbeh.2005.12.029_bib4","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","article-title":"Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial","volume":"156","author":"Anton","year":"1999","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.jcp.0000130555.63254.73","article-title":"A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence","volume":"24","author":"Anton","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.addbeh.2005.12.029_bib6","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1111\/j.1521-0391.2003.tb00496.x","article-title":"Current pharmacotherapies of alcoholism: A U.S. perspective","volume":"12","author":"Anton","year":"2003","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2005.12.029_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bjp.0701596","article-title":"Comparison of the effects of drugs on hyperexcitability induced in hippocampal slices by withdrawal from chronic ethanol consumption","volume":"123","author":"Bailey","year":"1998","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.addbeh.2005.12.029_bib8","first-page":"51","article-title":"Experience with sodium dipropylacetate in alcoholics and cases of drug addiction","volume":"58","author":"Bocci","year":"1976","journal-title":"Lavoro Neuropsichiatrico"},{"key":"10.1016\/j.addbeh.2005.12.029_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-2007-979203","article-title":"Treatment of alcohol withdrawal syndrome with gabapentin","volume":"32","author":"Bonnet","year":"1999","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/01.jcp.0000088905.24613.ad","article-title":"Treatment of acute alcohol withdrawal with gabapentin: Results from a controlled two-center trial","volume":"23","author":"Bonnet","year":"2003","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.addbeh.2005.12.029_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0278-5846(01)00234-2","article-title":"Treatment of alcohol withdrawal with gabapentin","volume":"26","author":"Bozikas","year":"2002","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0376-8716(02)00105-9","article-title":"The use of divalproex in alcohol relapse prevention: A pilot study","volume":"67","author":"Brady","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2005.12.029_bib13","first-page":"9981","article-title":"Depakene in the treatment of chronic alcoholism","volume":"28","author":"Brausseur","year":"1978","journal-title":"Therapiewoche"},{"key":"10.1016\/j.addbeh.2005.12.029_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4088\/JCP.v60n0911","article-title":"A case report of reduction in alcohol craving and protection against alcohol withdrawal by gabapentin","volume":"60","author":"Chatterjee","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/alcalc\/35.6.587","article-title":"A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse","volume":"35","author":"Chick","year":"2000","journal-title":"Alcohol and Alcoholism"},{"key":"10.1016\/j.addbeh.2005.12.029_bib16","first-page":"328","article-title":"The efficacy and safety of topiramate in the treatment of alcohol withdrawal","volume":"44","author":"Choi","year":"2005","journal-title":"Journal of the Korean Neuropsychiatric Association"},{"key":"10.1016\/j.addbeh.2005.12.029_bib17","series-title":"CAMPRAL\u00ae (acamprosate calcium) delayed-release tablets [approved label]","author":"Food and Drug Administration","year":"2004"},{"key":"10.1016\/j.addbeh.2005.12.029_bib18","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.281.14.1318","article-title":"Pharmacological treatment of alcohol dependence: A review of the evidence","volume":"281","author":"Garbutt","year":"1999","journal-title":"JAMA, The Journal of the American Medical Association"},{"issue":"Suppl. 1","key":"10.1016\/j.addbeh.2005.12.029_bib19","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1111\/j.1528-1157.2000.tb02174.x","article-title":"Clinical pharmacology of topiramate: A review","volume":"41","author":"Garnett","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.addbeh.2005.12.029_bib20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00004714-200212000-00009","article-title":"Lack of efficacy of naltrexone in the prevention of alcohol relapse: Results from a German multicenter study","volume":"22","author":"Gastpar","year":"2002","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.addbeh.2005.12.029_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000259166","article-title":"Acamprosate and prevention of relapse in alcoholics: Results of a randomized, placebo-controlled, double-blind study in out-patient alcoholics in the Netherlands, Belgium and Luxembourg","volume":"3","author":"Geerlings","year":"1997","journal-title":"European Addiction Research"},{"key":"10.1016\/j.addbeh.2005.12.029_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0011-393X(05)80480-1","article-title":"Effects of fluoxetine and Ca-acetyl-homotaurinate on alcohol intake in familial and nonfamilial alcoholic patients","volume":"52","author":"Gerra","year":"1992","journal-title":"Current Therapeutic Research"},{"key":"10.1016\/j.addbeh.2005.12.029_bib23","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1176\/ajp.153.9.1232a","article-title":"Valproate treatment of alcohol withdrawal and mania","volume":"153","author":"Hammer","year":"1996","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004714-200106000-00006","article-title":"Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: A factorial double-blind, placebo-controlled trial","volume":"21","author":"Heinala","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.addbeh.2005.12.029_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0028-3908(01)00171-X","article-title":"Two new actions of topiramate: Inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance","volume":"42","author":"Herrero","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.addbeh.2005.12.029_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0741-8329(89)90022-0","article-title":"Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid","volume":"6","author":"Hillbom","year":"1989","journal-title":"Alcohol"},{"key":"10.1016\/j.addbeh.2005.12.029_bib27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/01.ALC.0000134533.96915.08","article-title":"Progress in the development of topiramate for treating alcohol dependence: From a hypothesis to a proof-of-concept study","volume":"28","author":"Johnson","year":"2004","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2005.12.029_bib28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00023210-200519100-00005","article-title":"Recent advances in the development of treatments for alcohol and cocaine dependence: Focus on topiramate and other modulators of GABA or glutamate function","volume":"19","author":"Johnson","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.addbeh.2005.12.029_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130000371","article-title":"Neuropharmacological treatments for alcoholism: Scientific basis and clinical findings","volume":"149","author":"Johnson","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.addbeh.2005.12.029_bib30","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: A randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.addbeh.2005.12.029_bib31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02247375","article-title":"Attenuation of some alcohol-induced mood changes and the desire to drink by 5-HT3 receptor blockade: A preliminary study in healthy male volunteers","volume":"112","author":"Johnson","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.addbeh.2005.12.029_bib32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s002130050126","article-title":"Ritanserin in the treatment of alcohol dependence\u2014A multi-center clinical trial. Ritanserin Study Group","volume":"128","author":"Johnson","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.addbeh.2005.12.029_bib33","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/01.alc.0000174690.63787.fc","article-title":"Challenges and opportunities for medications development in alcoholism: An international perspective on collaborations between academia and industry","volume":"29","author":"Johnson","year":"2005","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2005.12.029_bib34","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jama.284.8.963","article-title":"Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial","volume":"284","author":"Johnson","year":"2000","journal-title":"JAMA, The Journal of the American Medical Association"},{"key":"10.1016\/j.addbeh.2005.12.029_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/ajp.157.1.151","article-title":"Gabapentin treatment for insomnia associated with alcohol dependence","volume":"157","author":"Karam-Hage","year":"2000","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.ALC.0000158840.07475.97","article-title":"Modulation of ethanol withdrawal-induced anxiety-like behavior during later withdrawals by treatment of early withdrawals with benzodiazepine\/gamma-aminobutyric acid ligands","volume":"29","author":"Knapp","year":"2005","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2005.12.029_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0376-8716(95)01100-D","article-title":"Carbamazepine treatment of cocaine dependence: A placebo-controlled trial","volume":"38","author":"Kranzler","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2005.12.029_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0893-133X(99)00135-9","article-title":"Naltrexone vs. nefazodone for treatment of alcohol dependence: A placebo-controlled trial","volume":"22","author":"Kranzler","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.addbeh.2005.12.029_bib39","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/01.ALC.0000075547.77464.76","article-title":"Effects of ondansetron in early- versus late-onset alcoholics: A prospective, open-label study","volume":"27","author":"Kranzler","year":"2003","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2005.12.029_bib40","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMoa011127","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"345","author":"Krystal","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.addbeh.2005.12.029_bib41","first-page":"182","article-title":"Acamprosate: A stabilizing factor in long-term withdrawal of alcoholic patients","volume":"50","author":"Ladewig","year":"1993","journal-title":"Therapeutische Umschau"},{"key":"10.1016\/j.addbeh.2005.12.029_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/00048678009159381","article-title":"Sodium valproate in the treatment of the alcohol withdrawal syndrome","volume":"14","author":"Lambie","year":"1980","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib43","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5694\/j.1326-5377.2002.tb04550.x","article-title":"Naltrexone in alcohol dependence: A randomised controlled trial of effectiveness in a standard clinical setting","volume":"176","author":"Latt","year":"2002","journal-title":"The Medical Journal of Australia"},{"key":"10.1016\/j.addbeh.2005.12.029_bib44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nn1182","article-title":"Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral tegmental area","volume":"7","author":"Laviolette","year":"2004","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.addbeh.2005.12.029_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF02255976","article-title":"The European acamprosate trials: Conclusions for research and therapy","volume":"8","author":"Lesch","year":"2001","journal-title":"Journal of Biomedical Science"},{"key":"10.1016\/j.addbeh.2005.12.029_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s002130050686","article-title":"Advances in development of medications for alcoholism treatment","volume":"139","author":"Litten","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.addbeh.2005.12.029_bib47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/alcalc\/agh067","article-title":"Challenges to medications development in treating alcohol dependence: An international perspective. Summary of a symposium held at the ESBRA Congress, Prague, 13 September 2003","volume":"39","author":"Littleton","year":"2004","journal-title":"Alcohol and Alcoholism"},{"key":"10.1016\/j.addbeh.2005.12.029_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1300\/J069v21n02_05","article-title":"Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention","volume":"21","author":"Longo","year":"2002","journal-title":"Journal of Addictive Diseases"},{"issue":"Suppl. 3","key":"10.1016\/j.addbeh.2005.12.029_bib49","first-page":"36","article-title":"GABA systems, benzodiazepines, and substance dependence","volume":"64","author":"Malcolm","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl.","key":"10.1016\/j.addbeh.2005.12.029_bib50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/10550490150504100","article-title":"Update on anticonvulsants for the treatment of alcohol withdrawal","volume":"10","author":"Malcolm","year":"2001","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2005.12.029_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/10550490290087910","article-title":"The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification","volume":"11","author":"Malcolm","year":"2002","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2005.12.029_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11606-002-0038-1","article-title":"The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial","volume":"17","author":"Malcolm","year":"2002","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.addbeh.2005.12.029_bib53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00023210-200418080-00002","article-title":"Pharmacotherapy of alcohol dependence: A review of the clinical data","volume":"18","author":"Mann","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.addbeh.2005.12.029_bib54","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archpsyc.56.8.719","article-title":"A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence","volume":"56","author":"Mason","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"Suppl. 6","key":"10.1016\/j.addbeh.2005.12.029_bib55","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1111\/j.1528-1157.1999.tb00932.x","article-title":"Gabapentin in the management of convulsive disorders","volume":"40","author":"McLean","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.addbeh.2005.12.029_bib56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/105504901750532148","article-title":"Predicting treatment response to naltrexone: The influence of craving and family history","volume":"10","author":"Monterosso","year":"2001","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2005.12.029_bib57","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1530-0277.2001.tb02170.x","article-title":"Naltrexone and cue exposure with coping and communication skills training for alcoholics: Treatment process and 1-year outcomes","volume":"25","author":"Monti","year":"2001","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2005.12.029_bib58","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1360-0443.2001.961115654.x","article-title":"Naltrexone for alcohol dependence: A randomized controlled trial","volume":"96","author":"Morris","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2005.12.029_bib59","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1530-0277.1997.tb03733.x","article-title":"A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence","volume":"21","author":"Mueller","year":"1997","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2005.12.029_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1081\/ADA-100100597","article-title":"Divalproex in the treatment of alcohol withdrawal","volume":"26","author":"Myrick","year":"2000","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.addbeh.2005.12.029_bib61","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1176\/ajp.155.11.1626j","article-title":"Gabapentin treatment of alcohol withdrawal","volume":"155","author":"Myrick","year":"1998","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib62","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence: A controlled study","volume":"49","author":"O'Malley","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib63","series-title":"Topamax\u00ae [package insert]","author":"Ortho-McNeil Pharmaceutical, Inc.","year":"2003"},{"key":"10.1016\/j.addbeh.2005.12.029_bib64","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00019442-199700540-00007","article-title":"Naltrexone as an adjunctive treatment for older patients with alcohol dependence","volume":"5","author":"Oslin","year":"1997","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib65","first-page":"239","article-title":"Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol","volume":"30","author":"Paille","year":"1995","journal-title":"Alcohol and Alcoholism"},{"key":"10.1016\/j.addbeh.2005.12.029_bib66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1192\/bjp.171.1.73","article-title":"Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study","volume":"171","author":"Pelc","year":"1997","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib67","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1528-1157.2000.tb00227.x","article-title":"Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients","volume":"41","author":"Petroff","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.addbeh.2005.12.029_bib68","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1530-0277.2000.tb04648.x","article-title":"Sertraline treatment for alcohol dependence: Interactive effects of medication and alcoholic subtype","volume":"24","author":"Pettinati","year":"2000","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2005.12.029_bib69","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1360-0443.1997.tb02873.x","article-title":"Acamprosate treatment in a long-term community-based alcohol rehabilitation programme","volume":"92","author":"Poldrugo","year":"1997","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.addbeh.2005.12.029_bib70","first-page":"CD005064","article-title":"Anticonvulsants for alcohol withdrawal","author":"Polycarpou","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.addbeh.2005.12.029_bib71","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1530-0277.2001.tb02354.x","article-title":"Divalproex sodium in alcohol withdrawal: A randomized double-blind placebo-controlled clinical trial","volume":"25","author":"Reoux","year":"2001","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2005.12.029_bib72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10550499808998350","article-title":"A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal","volume":"7","author":"Rosenthal","year":"1998","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2005.12.029_bib73","first-page":"65","article-title":"Does acamprosate diminish the appetite for alcohol in weaned alcoholics?","volume":"51","author":"Roussaux","year":"1996","journal-title":"Journal de Pharmacie de Belgique"},{"key":"10.1016\/j.addbeh.2005.12.029_bib74","first-page":"211","article-title":"A pilot study of topiramate (Topamax) in the treatment of tonic\u2013clonic seizures of alcohol withdrawal syndromes","volume":"56","author":"Rustembegovic","year":"2002","journal-title":"Medicinski Arhiv"},{"key":"10.1016\/j.addbeh.2005.12.029_bib75","first-page":"5","article-title":"A study of gabapentin in the treatment of tonic\u2013clonic seizures of alcohol withdrawal syndrome","volume":"58","author":"Rustembegovic","year":"2004","journal-title":"Medicinski Arhiv"},{"key":"10.1016\/j.addbeh.2005.12.029_bib76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.62.1.37","article-title":"Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: A double-blind placebo-controlled study","volume":"62","author":"Salloum","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib77","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1568007033482788","article-title":"GABA transporters and GABA-transaminase as drug targets","volume":"2","author":"Sarup","year":"2003","journal-title":"Current Drug Targets. CNS and Neurological Disorders"},{"key":"10.1016\/j.addbeh.2005.12.029_bib78","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archpsyc.1996.01830080023006","article-title":"Relapse prevention by acamprosate: Results from a placebo-controlled study on alcohol dependence","volume":"53","author":"Sass","year":"1996","journal-title":"Archives of General Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.addbeh.2005.12.029_bib79","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action","volume":"41","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.addbeh.2005.12.029_bib80","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0165-6147(97)89800-8","article-title":"Anti-craving compounds for ethanol: New pharmacological tools to study addictive processes","volume":"18","author":"Spanagel","year":"1997","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.addbeh.2005.12.029_bib81","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.addbeh.2005.12.029_bib82","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0006-3223(95)00432-7","article-title":"Ondansetron alters human alcohol intoxication","volume":"40","author":"Swift","year":"1996","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib83","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib84","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.1997.01830200071010","article-title":"Naltrexone and alcohol dependence: Role of subject compliance","volume":"54","author":"Volpicelli","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.addbeh.2005.12.029_bib85","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/08897070309511541","article-title":"Gabapentin for the treatment of ethanol withdrawal","volume":"24","author":"Voris","year":"2003","journal-title":"Substance Abuse"},{"key":"10.1016\/j.addbeh.2005.12.029_bib86","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0028-3908(97)00118-4","article-title":"The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome","volume":"36","author":"Watson","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.addbeh.2005.12.029_bib87","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0140-6736(96)91682-7","article-title":"Comparison of acamprosate and placebo in long-term treatment of alcohol dependence","volume":"347","author":"Whitworth","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.addbeh.2005.12.029_bib88","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1530-0277.1999.tb04105.x","article-title":"Ritanserin in relapse prevention in abstinent alcoholics: Results from a placebo-controlled double-blind international multicenter trial. Ritanserin in Alcoholism Work Group","volume":"23","author":"Wiesbeck","year":"1999","journal-title":"Alcoholism, Clinical and Experimental Research"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460305003011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460305003011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T12:58:43Z","timestamp":1683377923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460305003011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":88,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0306460305003011"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2005.12.029","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}